Publication of Project Plans
We are pleased to announce the Project Plans for the deliverables in the EUnetHTA 21 Service Contract (2021-2023) are published. They provide a general overview and describe the objectives, approach and timelines for all deliverables. All Project Plans have been validated by the Committee for Scientific Consistency and Quality (CSCQ) and endorsed by the EUnetHTA 21 Consortium Executive Board (CEB). For a future implementation of […]
[Closed] EUnetHTA 21 launches Open Call for JSC
EUnetHTA 21 is launching the first Open Call for applications from the pharmaceutical industry for four Joint Scientific Consultations (JSC), starting in January 2022. These will be consultations in parallel to EMA scientific advice and hence will focus on medicinal products. The Open Call will remain open from 8 November, 2021 to 7 December, 2021. […]
EUnetHTA 21 JSC – open calls
As one of the first milestones of EUnetHTA 21, we will soon launch the first open call to pharmaceutical industry for applications for the upcoming Joint Scientific Consultations, starting in January 2022. These will be consultations in parallel to EMA scientific advice and hence will focus on medicinal products. The launch of the open call […]
European HTA agencies launch the Heads of Agencies Group (HAG)
On 29 September 2021, the heads of 19 European HTA agencies came together and inaugurated a new HTA-focused collaborative network for high-level strategic exchange and discussion. In the coming period, the Heads of Agencies Group will focus on: Supporting the development of the basis for joint work on all HTA activities at the EU level […]
EUnetHTA 21
On 17 September 2021, the European Health and Digital Executive Agency (HaDEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work Supporting the Continuation of EU Cooperation on HTA. The contract will run for 24 months, and until 16 September 2023. EUnetHTA 21 work will build on the achievements and lessons […]
